Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Abstract Background About 8% of TB cases worldwide are estimated to have rifampicin-susceptible, isoniazid-resistant tuberculosis (Hr-TB), ranging from 5 to 11% regions. However, Hr-TB has not received much attention while comparing to be given high priority to the management of rifampicin-resistant...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2024-01-01
|
| Seri Bilgileri: | BMC Infectious Diseases |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12879-023-08909-2 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|